Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)-Reference-Cited by-同舟云学术

Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)

Published:2013-08-01 Issue:10 Volume:208 Page:1624-1628
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Fogel Jessica M.,Wang Lei,Parsons Teresa L.,Ou San-San,Piwowar-Manning Estelle,Chen Ying,Mudhune Victor O.,Hosseinipour Mina C.,Kumwenda Johnstone,Hakim James G.,Chariyalertsak Suwat,Panchia Ravindre,Sanne Ian,Kumarasamy Nagalingeswaran,Grinsztejn Beatriz,Makhema Joseph,Pilotto Jose,Santos Breno R.,Mayer Kenneth H.,McCauley Marybeth,Gamble Theresa,Bumpus Namandjé N.,Hendrix Craig W.,Cohen Myron S.,Eshleman Susan H.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/208/10/1624/13804373/jit390.pdf

Reference11 articles.

1. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2;Celum;N Engl J Med,2010

2. Unreported antiretroviral use by HIV-1 infected members of HIV-1 serodiscordant couples enrolling in an HIV-1 prevention clinical trial;Kahle,2012

3. Prevention of HIV-1 infection with early antiretroviral therapy;Cohen;N Engl J Med,2011

4. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

5. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ lamivudine /dolutegravir (TLD) roll-out in Mozambique;BMC Infectious Diseases;2024-07-29

2. The impact of non‐disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms;Vox Sanguinis;2024-04-15

3. HIV-1 Pretreatment and Acquired Antiretroviral Drug Resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique Running title: Pretreatment and Acquired HIV Drug Resistance in Mozambique;2024-04-08

4. Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART);Journal of the International AIDS Society;2023-10

5. Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study;Transfusion Medicine;2023-02-17